NO873996D0 - Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy-aminoalkaner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy-aminoalkaner.

Info

Publication number
NO873996D0
NO873996D0 NO873996A NO873996A NO873996D0 NO 873996 D0 NO873996 D0 NO 873996D0 NO 873996 A NO873996 A NO 873996A NO 873996 A NO873996 A NO 873996A NO 873996 D0 NO873996 D0 NO 873996D0
Authority
NO
Norway
Prior art keywords
aminoalkanes
preparation
therapeutic active
analogue procedure
aryloxy
Prior art date
Application number
NO873996A
Other languages
English (en)
Other versions
NO873996L (no
Inventor
Herbert Koeppe
Franz Esser
Wofram Gaida
Wolfgang Hoefke
Georg Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO873996D0 publication Critical patent/NO873996D0/no
Publication of NO873996L publication Critical patent/NO873996L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/261,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/301,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO873996A 1986-09-25 1987-09-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy-aminoalkaner. NO873996L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863632544 DE3632544A1 (de) 1986-09-25 1986-09-25 Neue aryloxy-aminoalkane, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO873996D0 true NO873996D0 (no) 1987-09-24
NO873996L NO873996L (no) 1988-03-28

Family

ID=6310301

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873996A NO873996L (no) 1986-09-25 1987-09-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive aryloksy-aminoalkaner.

Country Status (20)

Country Link
US (1) US4997833A (no)
EP (1) EP0264639A1 (no)
JP (1) JPS63119479A (no)
KR (1) KR880003929A (no)
AU (1) AU597727B2 (no)
CS (1) CS268837B2 (no)
DD (1) DD271519A5 (no)
DE (1) DE3632544A1 (no)
DK (1) DK501487A (no)
FI (1) FI874172A (no)
HU (1) HUT47264A (no)
IL (1) IL83979A0 (no)
NO (1) NO873996L (no)
NZ (1) NZ221939A (no)
PH (1) PH24246A (no)
PL (1) PL267876A1 (no)
PT (1) PT85785B (no)
SU (1) SU1609450A3 (no)
YU (1) YU176687A (no)
ZA (1) ZA877186B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02301596A (ja) * 1989-05-16 1990-12-13 Minoru Mitani アルミニウム又はその合金の表面処理方法
WO2006091716A2 (en) * 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3287215A (en) * 1961-06-15 1966-11-22 Colgate Palmolive Co 6-nitro-2-substituted-benzothiadiazines
US3210347A (en) * 1961-07-12 1965-10-05 Ciba Geigy Corp Benzothiadiazine-1, 1-dioxides
DE2757922A1 (de) * 1977-12-24 1979-06-28 Bayer Ag Substituierte alkylenamino-1.2.4- benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4536501A (en) * 1984-03-30 1985-08-20 E. R. Squibb & Sons, Inc. Substituted 4-phenoxy or 4-phenylthio prolines
DE3427309A1 (de) * 1984-07-25 1986-01-30 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-aryloxypropanolamine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
PL267876A1 (en) 1988-11-24
CS686987A2 (en) 1989-08-14
NO873996L (no) 1988-03-28
AU7895987A (en) 1988-03-31
DE3632544A1 (de) 1988-04-07
SU1609450A3 (ru) 1990-11-23
KR880003929A (ko) 1988-05-31
DK501487A (da) 1988-03-26
DK501487D0 (da) 1987-09-24
YU176687A (en) 1988-10-31
JPS63119479A (ja) 1988-05-24
CS268837B2 (en) 1990-04-11
AU597727B2 (en) 1990-06-07
ZA877186B (en) 1989-06-28
NZ221939A (en) 1990-01-29
IL83979A0 (en) 1988-02-29
PH24246A (en) 1990-05-04
PT85785A (de) 1987-10-01
EP0264639A1 (de) 1988-04-27
US4997833A (en) 1991-03-05
FI874172A (fi) 1988-03-26
FI874172A0 (fi) 1987-09-24
PT85785B (pt) 1990-08-31
HUT47264A (en) 1989-02-28
DD271519A5 (de) 1989-09-06

Similar Documents

Publication Publication Date Title
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO870240L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.